Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Investigational

144

US Approved Rx

37

Possibly Marketed Outside US

1

US Previously Marketed

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

Receptor tyrosine-protein kinase erbB-2

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

145

2015

5

2014

4

2024

4

2004

3

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Breast cancer

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

1

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Genentech

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Protein

148

Concept

26

Structurally Diverse

5

Nucleic Acid

4

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

FDA UNII

183

NCI_THESAURUS

183

SMS_ID

169

CAS

159

INN

152

All Match

Any Match

Exclude Selected

Exclude Selected

Protein Type

MONOCLONAL ANTIBODY

126

MONOCLONAL ANTIBODY CONJUGATE

12

BISPECIFIC ANTIBODY

7

BISPECIFIC MONOCLONAL FRAGMENTS

1

MONOCLONAL ANTIBODY FUSION PROTEIN

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

25

MUSCULO-SKELETAL SYSTEM

1

NERVOUS SYSTEM

1

VARIOUS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTINEOPLASTIC AGENTS

22

IMMUNOSUPPRESSANTS

4

DRUGS FOR TREATMENT OF BONE DISEASES

1

OTHER NERVOUS SYSTEM DRUGS

1

THERAPEUTIC RADIOPHARMACEUTICALS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

OTHER ANTINEOPLASTIC AGENTS

22

IMMUNOSUPPRESSANTS

4

DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION

1

OTHER NERVOUS SYSTEM DRUGS

1

OTHER THERAPEUTIC RADIOPHARMACEUTICALS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Monoclonal antibodies

21

Interleukin inhibitors

2

Selective immunosuppressants

2

Iodine (<sup>131</sup>I) compounds

1

Other antineoplastic agents

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

182

Salts, Hydrates, Esters, etc.

1

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Pharmacologic Substance[C1909]|Biological Agent[C307]|Antineoplastic Biological Agent" in comments (approximate match)

Showing 171 - 180 of 183 results

First page
Previous page
18
Next page
Next page

SGN-CD352A

ZX1I49XP7L

Status:

Investigational

Class:

CONCEPT

LY-3321367

2U7U2OB839

Status:

Investigational

Class:

CONCEPT

MEDI-4276

ZAM3L34SEW

Status:

Investigational

Class:

CONCEPT

GWN-323

WYJ05POC5C

Status:

Investigational

Class:

CONCEPT

BMS-986258

P339Q7RL7K

Status:

Investigational

Class:

CONCEPT

BHQ-880

IS3ESI44W5

Status:

Investigational

Class:

CONCEPT

BI-836858

JA7I0QFJ17

Status:

Investigational

Class:

CONCEPT

BI-836826

LB090AB8DB

Status:

Investigational

Class:

CONCEPT

MGD-007

OZ8N9U6CEH

Status:

Investigational

Class:

CONCEPT

MEDI-8852

OZS4TXB9VO

Status:

Investigational

Class:

CONCEPT

Showing 171 - 180 of 183 results

First page
Previous page
18
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1